Paper1348974
Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02.
Priebe TS and 3 others. Cancer Chemother Pharmacol, 1992. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02. Papers, record 1348974. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1348974
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Antineoplastic Agents | Major topic |
| Pancreatic Neoplasms | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Animals | |
| Antipyrine | |
| Cisplatin | |
| Drug Resistance | |
| Female | |
| Inulin | |
| Male | |
| Mammary Neoplasms, Experimental | |
| Membrane Glycoproteins | |
| Mice | |
| Mice, Inbred C57BL | |
| Neoplasm Transplantation | |
| RNA, Messenger |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-16672 | NCI NIH HHS | United States | P01CA016672 | PubMed and NIH | NIH RePORTER |
| CA-28034 | NCI NIH HHS | United States | R01CA028034 | PubMed and NIH | NIH RePORTER |
| P30CA016672 | NIH | NIH RePORTER |
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2911256 | Gene deletion, a mechanism of induced mutation by arabinosyl nucleosides. | Mutat Res | 1989 | https://conductscience.org/library/papers/2911256 | PubMed |
| 2 | 1913664 | Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha. | Cancer Res | 1991 | https://conductscience.org/library/papers/1913664 | PubMed |
| 3 | 6692374 | Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. | Cancer Res | 1984 | https://conductscience.org/library/papers/6692374 | PubMed |
| 4 | 6372991 | Tumor heterogeneity. | Cancer Res | 1984 | https://conductscience.org/library/papers/6372991 | PubMed |
| 5 | 4827349 | On the presence within tumours of clones that differ in sensitivity to cytostatic drugs. | Acta Pathol Microbiol Scand A | 1974 | https://conductscience.org/library/papers/4827349 | PubMed |
| 6 | 1568290 | Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1568290 | PubMed |
| 7 | 3863701 | Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice. | Cancer Lett | 1985 | https://conductscience.org/library/papers/3863701 | PubMed |
| 8 | 4644205 | Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine. | Cancer Res | 1972 | https://conductscience.org/library/papers/4644205 | PubMed |
| 9 | 3681376 | Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. | J Clin Oncol | 1987 | https://conductscience.org/library/papers/3681376 | PubMed |
| 10 | 3464801 | Sensitivity of proliferating cultured murine pancreatic tumor cells to selected antitumor agents. | J Natl Cancer Inst | 1986 | https://conductscience.org/library/papers/3464801 | PubMed |
| 11 | 6807556 | Metabolism and mechanisms of action of 9-(tetrahydro-2-furyl)-6-mercaptopurine in Chinese hamster ovary cells. | Chem Biol Interact | 1982 | https://conductscience.org/library/papers/6807556 | PubMed |
| 12 | 3391810 | Decreased bone growth arrest in weanling rats with multiple radiation fractions per day. | Int J Radiat Oncol Biol Phys | 1988 | https://conductscience.org/library/papers/3391810 | PubMed |
| 13 | 2652316 | Therapeutic implications of tumor heterogeneity. | Semin Oncol | 1989 | https://conductscience.org/library/papers/2652316 | PubMed |
| 14 | 6961973 | Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6961973 | PubMed |
| 15 | 2885085 | Multidrug resistance. | Cancer Surv | 1986 | https://conductscience.org/library/papers/2885085 | PubMed |
| 16 | 7248979 | Biological and experimental consequences of the zonal composition of solid tumors. | Cancer Res | 1981 | https://conductscience.org/library/papers/7248979 | PubMed |
| 17 | 6313211 | Identification of two distinct regulatory regions adjacent to the human beta-interferon gene. | Cell | 1983 | https://conductscience.org/library/papers/6313211 | PubMed |
| 18 | 518835 | Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. | Biochemistry | 1979 | https://conductscience.org/library/papers/518835 | PubMed |
| 19 | 2122232 | Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas. | Mol Cell Biol | 1990 | https://conductscience.org/library/papers/2122232 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37461129 | Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy. | Mol Cancer Ther | 2023 | https://conductscience.org/library/papers/37461129 | PubMed |
| 37244938 | Myeloid MyD88 restricts CD8+ T cell response to radiation therapy in pancreatic cancer. | Sci Rep | 2023 | https://conductscience.org/library/papers/37244938 | PubMed |
| 37072485 | Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help. | Sci Rep | 2023 | https://conductscience.org/library/papers/37072485 | PubMed |
| 36056093 | ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control. | Sci Rep | 2022 | https://conductscience.org/library/papers/36056093 | PubMed |
| 33816320 | Defining Immunogenic and Radioimmunogenic Tumors. | Front Oncol | 2021 | https://conductscience.org/library/papers/33816320 | PubMed |
| 31727378 | Shear Wave Elastography Can Differentiate between Radiation-Responsive and Non-responsive Pancreatic Tumors: An ex Vivo Study with Murine Models. | Ultrasound Med Biol | 2020 | https://conductscience.org/library/papers/31727378 | PubMed |
| 30726287 | Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma. | PLoS One | 2019 | https://conductscience.org/library/papers/30726287 | PubMed |
| 30584324 | A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30584324 | PubMed |
| 27602953 | Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy. | Oncotarget | 2016 | https://conductscience.org/library/papers/27602953 | PubMed |
| 23936036 | The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor. | PLoS One | 2013 | https://conductscience.org/library/papers/23936036 | PubMed |
| 22761754 | Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy. | PLoS One | 2012 | https://conductscience.org/library/papers/22761754 | PubMed |
| 20405291 | cis-Hydroxyproline-mediated pancreatic carcinoma growth inhibition in mice. | Int J Colorectal Dis | 2010 | https://conductscience.org/library/papers/20405291 | PubMed |
| 11558631 | A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy. | Int J Pancreatol | 2001 | https://conductscience.org/library/papers/11558631 | PubMed |
| 9764577 | Tau expression in model adenocarcinomas correlates with docetaxel sensitivity in tumour-bearing mice. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9764577 | PubMed |
| 1568290 | Mechanisms of resistance to 6-thioguanine in a murine pancreatic tumor. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1568290 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1348974
GET https://conductscience.org/api/papers/v1/1348974/authors